The short answer
Garlic may lower glucose modestly, but added hypoglycemia with glipizide has not been established. A product review is sensible because glipizide itself can cause low glucose.
What this answer covers
Oral Allium sativum supplements; garlic oils, aged extracts, powder, food portions and blends are not interchangeable.
- Supplement or preparation
- Allium sativum
- Medication ingredient
- glipizide
What the evidence supports
NIH guidance describes a small glucose-lowering effect of garlic supplements in diabetes. That supports considering the supplement when reviewing glucose changes, without proving that garlic causes clinically low glucose during glipizide treatment.
A diabetes trial is not an exact interaction trial
One study combined garlic with olive oil and several medicines, including glimepiride and metformin. It reported lipid improvements. It did not establish a garlic-glipizide hypoglycemia effect, and the ingredients cannot be disentangled from that abstract.
Check the actual preparation
Supplement processing changes the exposure. A concentrated capsule or oil is not automatically equivalent to culinary garlic, and a blend may contain other glucose-active ingredients. The botanical name alone does not give a predictable effect.
Review changes in glucose
Discuss the exact product and amount with the diabetes team before starting or changing it. Follow your established glucose-monitoring and low-glucose treatment plan; do not adjust glipizide yourself. There is no established supplement-specific dose cut or protective spacing interval.
Evidence and practical considerations
Side effects & toxicity
Modest supplement glucose lowering and a mixed glimepiride lipid trial do not establish clinical hypoglycemia with exact glipizide.
- Exact scope
- Oral Allium sativum supplements; garlic oils, aged extracts, powder, food portions and blends are not interchangeable. with Oral glipizide RxCUI4821 IN, immediate and extended release distinguished.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- Exact source preparation, medication and endpoint limits apply; no universal dose change or spacing.
Factors that may matter: Formulation; Dose and duration; Meal pattern; Other glucose-lowering agents; Kidney and liver function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients with type 2 diabetes receiving glipizide.
Glipizide can cause severe hypoglycemia; added glucose-lowering agents warrant observation. Nicotinic acid can worsen glycemic control; withdrawal also needs observation.
How this applies: Exact glipizide formulation and supplement preparation matter; other sulfonylureas and glucose efficacy endpoints are not automatically glipizide hypoglycemia evidence.
Separate formulations and meal instructions; no automatic transfer of immediate-release antacid pharmacokinetics to XL. Does not establish a risk rate for these herbs.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients with type 2 diabetes receiving glipizide.
Glipizide can cause severe hypoglycemia; added glucose-lowering agents warrant observation. Nicotinic acid can worsen glycemic control; withdrawal also needs observation.
How this applies: Exact glipizide formulation and supplement preparation matter; other sulfonylureas and glucose efficacy endpoints are not automatically glipizide hypoglycemia evidence.
Separate formulations and meal instructions; no automatic transfer of immediate-release antacid pharmacokinetics to XL. Does not establish a risk rate for these herbs.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 160adults with type 2 diabetes and dyslipidemia.
Combination intervention improved lipid measurements; inspected abstract does not establish hypoglycemia.
How this applies: Exact glipizide formulation and supplement preparation matter; other sulfonylureas and glucose efficacy endpoints are not automatically glipizide hypoglycemia evidence.
Different sulfonylurea and multiple cointerventions; lipid outcomes cannot establish garlic-glipizide low-glucose risk.
Source 4: federal health guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: Users of the specified supplement.
Garlic supplements may reduce glucose slightly in people with diabetes.
How this applies: Exact glipizide formulation and supplement preparation matter; other sulfonylureas and glucose efficacy endpoints are not automatically glipizide hypoglycemia evidence.
Modest glucose lowering does not prove added clinical hypoglycemia with glipizide.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact glipizide article preserving formulation, preparation and glucose endpoint distinctions. | |
| Research summary published |
Article revision: b931367111f27869
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.